What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials (Q45722665)
Jump to navigation
Jump to search
scientific article published in July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials |
scientific article published in July 2003 |
Statements
1 reference
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials (English)
1 reference
Lawrence Corey
1 reference
Michael G Hudgens
1 reference
Steven G Self
1 reference
Scott M Hammer
1 reference
Peter B Gilbert
1 reference
Victor G DeGruttola
1 reference
1 July 2003
1 reference
1 reference
188
1 reference
2
1 reference
179-193
1 reference
Identifiers
1 reference
1 reference